PURCHASE, N.Y., Feb. 5 Nutrition 21, Inc.(Nasdaq: NXXI), a growing developer and marketer of nutritional supplementsunder the Chromax(R), Diabetes Essentials(TM) and Iceland Health(R) brandsthat help consumers manage blood sugar levels, improve cardiovascular health,enhance memory, and address chronic joint pain, will report financial resultsfor the second quarter of fiscal year 2008, ended December 31, 2007 on Monday,February 11, 2008, after market close. The Company has scheduled a conferencecall to discuss the results of the quarter on Tuesday, February 12, 2008, at8:30AM ET.
Participants can dial (866) 562-9910 or (706) 679-5064 to access theconference call, or can listen via a live Internet web cast, which can befound at http://www.nutrition21.com. A replay of the call is available byvisiting http://www.nutrition21.com for the next 30 days or by calling(800) 642-1687 or (706) 645-9291, access code 32156566, through February 14,2008.
About Nutrition 21
Nutrition 21, Inc. (NASDAQ: NXXI), headquartered in Purchase, NY, is anutritional bioscience company and the maker of chromium picolinate-based andomega-3 fish oil-based supplements with health benefits substantiated byclinical research. Nutrition 21 holds more than 30 patents for nutritionproducts and uses. Nutrition 21's portfolio of health and wellness brandsinclude: Chromax(R), Core4Life(TM) Advanced Memory Formula(TM), DiabetesEssentials(TM), Iceland Health(R) Maximum Strength Omega-3 and IcelandHealth(R) Joint Relief. The company also manufactures private labelsupplements and ingredients for third parties. Nutrition 21 distributes itsproducts nationally through more than 29,000 major food, drug and super centerretailers as well as internationally. More information is available athttp://www.nutrition21.com/.Contacts: Nutrition 21, Inc. Lytham Partners, LLC Maryrose Lombardo Joe Diaz, Robert Blum, Joe Dorame 914-701-4525 (602) 889-9700
SOURCE Nutrition 21, Inc.